COVID19 Solutions: Women Accelerator Program by IIIT Hyderabad [Grants Upto Rs. 25L]: Applications Open

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on linkedin
LinkedIn
Share on email
Email
About

IIIT Hyderabad announces COVID-19 Solutions: Women Accelerator Program, a CIE-IIITH – PRIF Social Impact Incubator partnership.

The Pernod Ricard Social Impact Incubator aims to provide a platform for Women Entrepreneurs and Women-led Social Enterprises with access to mentorship, business development support, technology and more than ₹4 crores of incubation and fellowship support.

The WE program invites applications exclusively from women entrepreneurs and women-led enterprises working towards driving social impact aligned with the United Nations Sustainable Development Goals and NITI Aayog national priorities.

Objectives

COVID-19 outbreak has created devastating effects on healthcare systems and people. We can tide back the situation with hacks and innovative solutions.The accelerator program is believed to provide a platform for Women Entrepreneurs and Women-led  Enterprises  with access to mentorship, deployment, technology support and up to ₹25 Lakhs Grant to fight back against COVID-19

It is a cohort-based program supported by CFHE at IIT Hyderabad, AIC CCMB, RICH, TIE Hyderabad.

Focus Areas
  1. Home Care: Mobile healthcare technologies
  2. Elderly Care: AI-based predictive technologies for risk assessment
  3. Hardware Devices: Point of care devices
  4. Preventive Healthcare: Analytics leveraged to prevent diseases onset
Benefits
  • Up to Rs. 25 Lakhs grants and follow on funding support
  • Access to hardware prototyping/ Maker Lab
  • Research, technology, and market mentoring
How to Apply?

Interested candidates can apply online by clicking here.

Contact

Email ID: incubation@iiith.org

For further details, click here.

Disclaimer : We try to ensure that the information we post on Noticebard.com is accurate. However, despite our best efforts, some of the content may contain errors. You can trust us, but please conduct your own checks too.

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on linkedin
LinkedIn
Share on email
Email

Leave a Comment